Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Other Accumulated Expenses (2022 - 2025)

Acro Biomedical (ACBM) has 4 years of Other Accumulated Expenses data on record, last reported at $1100.0 in Q4 2025.

  • For Q4 2025, Other Accumulated Expenses changed 0.0% year-over-year to $1100.0; the TTM value through Dec 2025 reached $1100.0, changed 0.0%, while the annual FY2025 figure was $1100.0, 0.0% changed from the prior year.
  • Other Accumulated Expenses reached $1100.0 in Q4 2025 per ACBM's latest filing, roughly flat from $1100.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $79078.0 in Q3 2023 and bottomed at $1100.0 in Q4 2023.
  • Average Other Accumulated Expenses over 4 years is $40029.0, with a median of $39963.0 recorded in 2022.
  • Peak YoY movement for Other Accumulated Expenses: tumbled 98.6% in 2023, then changed 0.0% in 2024.
  • A 4-year view of Other Accumulated Expenses shows it stood at $78826.0 in 2022, then crashed by 98.6% to $1100.0 in 2023, then changed by 0.0% to $1100.0 in 2024, then changed by 0.0% to $1100.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $1100.0 in Q4 2025, $1100.0 in Q4 2024, and $1100.0 in Q4 2023.